These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17200728)

  • 1. Effects of chemotherapy and/or radiotherapy on survivin expression in ovarian cancer.
    Zhang B; Pan JS; Liu JY; Han SP; Hu G; Wang B
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):619-25. PubMed ID: 17200728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
    Ikeguchi M; Nakamura S; Kaibara N
    Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for epithelial ovarian cancer--role of apoptosis.
    Dutta T; Sharma H; Kumar L; Dinda AK; Kumar S; Bhatla N; Singh N
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):427-35. PubMed ID: 15906030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):773-8. PubMed ID: 16525657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.
    Rödel F; Hoffmann J; Distel L; Herrmann M; Noisternig T; Papadopoulos T; Sauer R; Rödel C
    Cancer Res; 2005 Jun; 65(11):4881-7. PubMed ID: 15930309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
    Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
    Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J; O'brate A; Zelnak A; Giannakakou P
    Cancer Res; 2004 Dec; 64(23):8708-14. PubMed ID: 15574781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5.
    Huang Y; Jin H; Liu Y; Zhou J; Ding J; Cheng KW; Yu Y; Feng Y
    Endocr Relat Cancer; 2011 Feb; 18(1):13-26. PubMed ID: 20943720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
    Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
    Cheng B; Yang X; Han Z; An L; Liu S
    Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.